ID

16951

Description

Non-Myeloablative Allogeneic Stem Cell Transplantation; ODM derived from: https://clinicaltrials.gov/show/NCT00525876

Link

https://clinicaltrials.gov/show/NCT00525876

Keywords

Versions (1)
  1. 8/15/16 8/15/16 -
Uploaded on

August 15, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Lymphoma NCT00525876

English

Eligibility Lymphoma NCT00525876

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00525876
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patients can be as old as 70 years.
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
2. they must have a diagnosis of mcl, either (1) recurrent, (2) newly diagnosed (after cytoreduction with conventional chemotherapy) but with high-risk features (blastic or blastoid features, leukemic phase, or elevated b^2 microglobulin (> 3).
Description

Recurrent MCL or newly diagnosed MCL with high risk features

Data type

boolean

Alias
UMLS CUI [1,1]
C0334634
UMLS CUI [1,2]
C0277556
UMLS CUI [2,1]
C0334634
UMLS CUI [2,2]
C0852709
UMLS CUI [3,1]
C0334634
UMLS CUI [3,2]
C0201910
UMLS CUI [4]
C1332569
3. patients that have received prior conventional chemotherapy but have not achieved complete response (cr).
Description

Patients that have received prior conventional chemotherapy but have not achieved complete response

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0521982
4. disease must be chemosensitive, (ie, patients must not have had a partial response to prior therapy).
Description

Chemosensitivity

Data type

boolean

Alias
UMLS CUI [1]
C2347610
5. patients whose disease failed to respond to a previous autologous transplantation may also be eligible.
Description

Patients whose disease failed to respond to a previous autologous transplantation

Data type

boolean

Alias
UMLS CUI [1,1]
C0040736
UMLS CUI [1,2]
C3844738
6. patients must have a matched or 1 antigen mismatched sibling or unrelated donor.
Description

Matched or 1 antigen mismatched sibling or unrelated donor

Data type

boolean

Alias
UMLS CUI [1,1]
C0375877
UMLS CUI [1,2]
C0019633
7. point scale (ps) </= 2.
Description

ECOG

Data type

boolean

Alias
UMLS CUI [1]
C1520224
8. inclusion criteria for immunomodulation post transplantation: patients can be as old as 70 years.
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
9. patients must have a diagnosis of mcl or cll with one of the following characteristics: 1. patients who develop disease progression or do not experience a cr within 3 months post-allogeneic transplantation 2. patients with a weak chimerism (any mixed chimerism of donor t cells in patients receiving campath by day 90, and less than 20% for patients not receiving campath) or a drop of 20% or more with an amount of donor cells present in the blood < 50% by pcr. patients must have the same donor of the original transplant willing to donate lymphocytes. 4. ps </ 2.
Description

Inclusion Criteria for Immunomodulation: MCL or CLL

Data type

boolean

Alias
UMLS CUI [1]
C0334634
UMLS CUI [2]
C0023434
UMLS CUI [3,1]
C0242656
UMLS CUI [3,2]
C2242529
UMLS CUI [4,1]
C0521982
UMLS CUI [4,2]
C2242529
UMLS CUI [5]
C3703928
UMLS CUI [6,1]
C1512034
UMLS CUI [6,2]
C0375877
UMLS CUI [7]
C1520224
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. past history of anaphylaxis following exposure to rat- or mouse-derived cdr-grafted humanized monoclonal antibodies.
Description

history of anaphylaxis following exposure to rat- or mouse-derived cdr-grafted humanized monoclonal antibodies

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C2985546
2. less than 4 weeks since prior chemotherapy counted from first day of treatment regimen.
Description

Latest chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0392920
3. pregnancy or lactation.
Description

pregnancy or lactation

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
4. hiv or htlv-i positivity.
Description

HIV or HTLV-I positivity

Data type

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2]
C0020097
5. serum creatinine concentration > 1.6 mg/dl or serum bilirubin > 2.0 mg/dl unless due to tumor
Description

Serum creatinine, serum bilirubin

Data type

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0428441
6. pulmonary function test - carbon monoxide diffusing capacity < 40%
Description

carbon monoxide diffusing capacity

Data type

boolean

Alias
UMLS CUI [1]
C0199525
7. cardiac ejection fraction < 40% of predicted levels (by multiple-gated acquisition or echocardiography).
Description

Cardiac ejection fraction

Data type

boolean

Alias
UMLS CUI [1]
C0232174
8. severe concomitant medical or psychiatric illness.
Description

concomitant medical or psychiatric illness

Data type

boolean

Alias
UMLS CUI [1]
C0009488
Back to the top of the page

Similar models

Eligibility Lymphoma NCT00525876

1 forms
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00525876
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
1. patients can be as old as 70 years.
boolean
C0001779 (UMLS CUI [1])
Recurrent MCL or newly diagnosed MCL with high risk features
Item
2. they must have a diagnosis of mcl, either (1) recurrent, (2) newly diagnosed (after cytoreduction with conventional chemotherapy) but with high-risk features (blastic or blastoid features, leukemic phase, or elevated b^2 microglobulin (> 3).
boolean
C0334634 (UMLS CUI [1,1])
C0277556 (UMLS CUI [1,2])
C0334634 (UMLS CUI [2,1])
C0852709 (UMLS CUI [2,2])
C0334634 (UMLS CUI [3,1])
C0201910 (UMLS CUI [3,2])
C1332569 (UMLS CUI [4])
Patients that have received prior conventional chemotherapy but have not achieved complete response
Item
3. patients that have received prior conventional chemotherapy but have not achieved complete response (cr).
boolean
C0392920 (UMLS CUI [1,1])
C0521982 (UMLS CUI [1,2])
Chemosensitivity
Item
4. disease must be chemosensitive, (ie, patients must not have had a partial response to prior therapy).
boolean
C2347610 (UMLS CUI [1])
Patients whose disease failed to respond to a previous autologous transplantation
Item
5. patients whose disease failed to respond to a previous autologous transplantation may also be eligible.
boolean
C0040736 (UMLS CUI [1,1])
C3844738 (UMLS CUI [1,2])
Matched or 1 antigen mismatched sibling or unrelated donor
Item
6. patients must have a matched or 1 antigen mismatched sibling or unrelated donor.
boolean
C0375877 (UMLS CUI [1,1])
C0019633 (UMLS CUI [1,2])
ECOG
Item
7. point scale (ps) </= 2.
boolean
C1520224 (UMLS CUI [1])
Age
Item
8. inclusion criteria for immunomodulation post transplantation: patients can be as old as 70 years.
boolean
C0001779 (UMLS CUI [1])
Inclusion Criteria for Immunomodulation: MCL or CLL
Item
9. patients must have a diagnosis of mcl or cll with one of the following characteristics: 1. patients who develop disease progression or do not experience a cr within 3 months post-allogeneic transplantation 2. patients with a weak chimerism (any mixed chimerism of donor t cells in patients receiving campath by day 90, and less than 20% for patients not receiving campath) or a drop of 20% or more with an amount of donor cells present in the blood < 50% by pcr. patients must have the same donor of the original transplant willing to donate lymphocytes. 4. ps </ 2.
boolean
C0334634 (UMLS CUI [1])
C0023434 (UMLS CUI [2])
C0242656 (UMLS CUI [3,1])
C2242529 (UMLS CUI [3,2])
C0521982 (UMLS CUI [4,1])
C2242529 (UMLS CUI [4,2])
C3703928 (UMLS CUI [5])
C1512034 (UMLS CUI [6,1])
C0375877 (UMLS CUI [6,2])
C1520224 (UMLS CUI [7])
Item Group
C0680251 (UMLS CUI)
history of anaphylaxis following exposure to rat- or mouse-derived cdr-grafted humanized monoclonal antibodies
Item
1. past history of anaphylaxis following exposure to rat- or mouse-derived cdr-grafted humanized monoclonal antibodies.
boolean
C0020517 (UMLS CUI [1,1])
C2985546 (UMLS CUI [1,2])
Latest chemotherapy
Item
2. less than 4 weeks since prior chemotherapy counted from first day of treatment regimen.
boolean
C0392920 (UMLS CUI [1])
pregnancy or lactation
Item
3. pregnancy or lactation.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
HIV or HTLV-I positivity
Item
4. hiv or htlv-i positivity.
boolean
C0019699 (UMLS CUI [1])
C0020097 (UMLS CUI [2])
Serum creatinine, serum bilirubin
Item
5. serum creatinine concentration > 1.6 mg/dl or serum bilirubin > 2.0 mg/dl unless due to tumor
boolean
C0201976 (UMLS CUI [1])
C0428441 (UMLS CUI [2])
carbon monoxide diffusing capacity
Item
6. pulmonary function test - carbon monoxide diffusing capacity < 40%
boolean
C0199525 (UMLS CUI [1])
Cardiac ejection fraction
Item
7. cardiac ejection fraction < 40% of predicted levels (by multiple-gated acquisition or echocardiography).
boolean
C0232174 (UMLS CUI [1])
concomitant medical or psychiatric illness
Item
8. severe concomitant medical or psychiatric illness.
boolean
C0009488 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial